Healthcare provider profile · identity verified

Nesib Ali, MD

Family Practice · SAN BERNARDINO, CA · NPI 1497725261

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	186
Amlodipine Besylate	Amlodipine Besylate	328	105
Metformin Hcl	Metformin Hcl	322	104
Lisinopril	Lisinopril	286	89
Losartan Potassium	Losartan Potassium	280	97
Levothyroxine Sodium	Levothyroxine Sodium	262	74
Gabapentin	Gabapentin	205	44
Glipizide	Glipizide	186	53
Albuterol Sulfate Hfa	Albuterol Sulfate	173	64
Hydrochlorothiazide	Hydrochlorothiazide	168	50
Lovastatin	Lovastatin	159	49
Metoprolol Tartrate	Metoprolol Tartrate	159	38
Eliquis	Apixaban	132	27
Omeprazole	Omeprazole	129	43
Simvastatin	Simvastatin	127	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	27
Metoprolol Succinate	Metoprolol Succinate	115	42
Atenolol	Atenolol	111	33
Fluticasone Propionate	Fluticasone Propionate	110	33
Furosemide	Furosemide	109	41
Tamsulosin Hcl	Tamsulosin Hcl	105	36
Jardiance	Empagliflozin	100	17
Carvedilol	Carvedilol	93	30
Benazepril Hcl	Benazepril Hcl	85	27
Buspirone Hcl	Buspirone Hcl	83	24
Pravastatin Sodium	Pravastatin Sodium	74	19
Allopurinol	Allopurinol	70	23
Famotidine	Famotidine	70	24
Finasteride	Finasteride	64	18
Clopidogrel	Clopidogrel Bisulfate	61	22
Alendronate Sodium	Alendronate Sodium	57	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	15
Nifedipine Er	Nifedipine	52	18
Enalapril Maleate	Enalapril Maleate	51	15
Pantoprazole Sodium	Pantoprazole Sodium	51	22
Tramadol Hcl	Tramadol Hcl	50	13
Triamcinolone Acetonide	Triamcinolone Acetonide	48	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	12
Lantus	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Potassium Chloride	Potassium Chloride	39	14
Rosuvastatin Calcium	Rosuvastatin Calcium	39	14
Warfarin Sodium	Warfarin Sodium	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	21
Ibuprofen	Ibuprofen	36	13
Clonidine Hcl	Clonidine Hcl	34	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	11
Valsartan	Valsartan	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	31	11
Sildenafil Citrate	Sildenafil Citrate	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Trazodone Hcl	Trazodone Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	13
Hydralazine Hcl	Hydralazine Hcl	26	12
Felodipine Er	Felodipine	25	suppressed
Insulin Lispro	Insulin Lispro	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Cephalexin	Cephalexin	24	21
Chlorthalidone	Chlorthalidone	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Nystatin	Nystatin	21	13
Propranolol Hcl	Propranolol Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Methylprednisolone	Methylprednisolone	20	14
Synthroid	Levothyroxine Sodium	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Cimetidine	Cimetidine	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Donepezil Hcl	Donepezil Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Easy-Touch Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Zonisamide	Zonisamide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Ambrisentan	Ambrisentan	12	suppressed
Azithromycin	Azithromycin	12	12
Febuxostat	Febuxostat	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error